This business about low T – you know, all those ads you see geared to convincing aging men(and lots of younger ones, too) that they have low testosterone levels and that if they just raise those levels, they will end up much happier, healthier, and less horny of course – is something that can only be explained on the basis of pharmaceutical companies needing to make more money than they currently are making (with many doctors along as willing accomplices, of course).
Why is that?
Because based on current data, we simply don’t know enough about what constitutes “normal” testosterone levels for the vast majority of men, given that those levels can vary with mood, time of day, time of year, exercise, you name it.
But that hasn’t prevented a lucrative industry geared to raising testosterone levels with supplements from springing up although the net benefit for most men of testosterone therapy is probably very minor, and for many, the potential risks likely outweigh the gains.
So if you’ve been sitting on the fence about whether to take testosterone or not, you may be interested in a new study that concluded that men who use testosterone therapy have a significantly raised risk of suffering a deep vein thrombosis, in English, that’s a blood clot in the leg, which can lead to pulmonary emboli (blood clots breaking off the leg clot and traveling to the lungs), which is a dangerous complication that can kill you.
But that’s not all the cardiovascular risks from testosterone therapy because other studies have found that it also raises the risks of heart attacks and strokes, risks that seem to be highest in the first 6 months after initiating treatment.
But don’t just take my opinion that this is a problematic route to start on.
Here are the words of one of the authors of the study: “Men without hypogonadism . . . might be needlessly putting themselves at a higher risk for a deep vein thrombosis or pulmonary embolism with these therapies, especially younger men.”